Source:http://linkedlifedata.com/resource/pubmed/id/15838654
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-7-27
|
pubmed:abstractText |
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is one of the best characterized nuclear hormone receptors (NHRs) in the superfamily of ligand-activated transcriptional factors. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. The present study was undertaken to investigate PPAR-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase MMP-9 and MMP-2 activities on leukemia K562 and HL-60 cells in vitro. The results revealed that PPAR-gamma expression was detectable in the two kinds of leukemia cells; Both 15-deoxy-delta(12,14)-prostaglandin J2(15d-PGJ2) and troglitazone (TGZ) have significant growth inhibition effects on these two kinds of leukemia cells. These two PPAR-gamma ligands could inhibit the leukemic cell adhesion to the extracellular matrix (ECM) proteins and the invasion through matrigel matrix. The expressions of MMP-9 and MMP-2 as well as their gelatinolytic activities in both HL-60 and K562 cells were inhibited by 15d-PGJ2 and TGZ significantly. We therefore conclude that PPAR-gamma ligands 15d-PGJ2 and TGZ have significant growth inhibition effects on myeloid leukemia cells in vitro, and that PPAR-gamma ligands can inhibit K562 and HL-60 cell adhesion to and invasion through ECM as well as downregulate MMP-9 and MMP-2 expressions. The data suggest that PPAR-gamma ligands may serve as potential anti-leukemia reagents.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/15-deoxyprostaglandin J2,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chromans,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloproteases,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin D2,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/troglitazone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0344-5704
|
pubmed:author |
pubmed-author:HouMingM,
pubmed-author:HuangRenweiR,
pubmed-author:LinDongjunD,
pubmed-author:LiuJiajunJ,
pubmed-author:LoolA LAL,
pubmed-author:LuHuilingH,
pubmed-author:PanXianglinX,
pubmed-author:QuLinL,
pubmed-author:SongYuqinY,
pubmed-author:WuXiangyuanX,
pubmed-author:WuXinyaoX,
pubmed-author:YuZ PZP,
pubmed-author:ZhangMaohongM,
pubmed-author:ZhengJingJ
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
400-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15838654-Antineoplastic Agents,
pubmed-meshheading:15838654-Chromans,
pubmed-meshheading:15838654-Extracellular Matrix,
pubmed-meshheading:15838654-Humans,
pubmed-meshheading:15838654-Leukemia, Myeloid,
pubmed-meshheading:15838654-Metalloproteases,
pubmed-meshheading:15838654-PPAR gamma,
pubmed-meshheading:15838654-Prostaglandin D2,
pubmed-meshheading:15838654-Thiazolidinediones,
pubmed-meshheading:15838654-Tumor Cells, Cultured
|
pubmed:year |
2005
|
pubmed:articleTitle |
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
|
pubmed:affiliation |
Department of Haematology and Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Guangzhou, 510630, P.R. China, liujj@gzsums.edu.cn.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|